These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 27529149)

  • 21. Distinct Reproductive Risk Profiles for Intrinsic-Like Breast Cancer Subtypes: Pooled Analysis of Population-Based Studies.
    Jung AY; Ahearn TU; Behrens S; Middha P; Bolla MK; Wang Q; Arndt V; Aronson KJ; Augustinsson A; Beane Freeman LE; Becher H; Brenner H; Canzian F; Carey LA; ; Czene K; Eliassen AH; Eriksson M; Evans DG; Figueroa JD; Fritschi L; Gabrielson M; Giles GG; Guénel P; Hadjisavvas A; Haiman CA; Håkansson N; Hall P; Hamann U; Hoppe R; Hopper JL; Howell A; Hunter DJ; Hüsing A; Kaaks R; Kosma VM; Koutros S; Kraft P; Lacey JV; Le Marchand L; Lissowska J; Loizidou MA; Mannermaa A; Maurer T; Murphy RA; Olshan AF; Olsson H; Patel AV; Perou CM; Rennert G; Shibli R; Shu XO; Southey MC; Stone J; Tamimi RM; Teras LR; Troester MA; Truong T; Vachon CM; Wang SS; Wolk A; Wu AH; Yang XR; Zheng W; Dunning AM; Pharoah PDP; Easton DF; Milne RL; Chatterjee N; Schmidt MK; García-Closas M; Chang-Claude J
    J Natl Cancer Inst; 2022 Dec; 114(12):1706-1719. PubMed ID: 35723569
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Locoregional Recurrence Following Breast Cancer Surgery in the Trastuzumab Era: A Systematic Review by Subtype.
    McGuire A; Lowery AJ; Kell MR; Kerin MJ; Sweeney KJ
    Ann Surg Oncol; 2017 Oct; 24(11):3124-3132. PubMed ID: 28755141
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reproductive and hormonal risk factors for luminal, HER2-overexpressing, and triple-negative breast cancer in Japanese women.
    Islam T; Matsuo K; Ito H; Hosono S; Watanabe M; Iwata H; Tajima K; Tanaka H
    Ann Oncol; 2012 Sep; 23(9):2435-2441. PubMed ID: 22328736
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Descriptive analysis of molecular subtypes in Tunisian breast cancer.
    Fourati A; Boussen H; El May MV; Goucha A; Dabbabi B; Gamoudi A; Sfar R; Rahal K; El May A; Ben Abdallah M
    Asia Pac J Clin Oncol; 2014 Jun; 10(2):e69-74. PubMed ID: 23176549
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Breast cancer risk factors, survival and recurrence, and tumor molecular subtype: analysis of 3012 women from an indigenous Asian population.
    Abubakar M; Sung H; Bcr D; Guida J; Tang TS; Pfeiffer RM; Yang XR
    Breast Cancer Res; 2018 Sep; 20(1):114. PubMed ID: 30227867
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reproductive profiles and risk of breast cancer subtypes: a multi-center case-only study.
    Brouckaert O; Rudolph A; Laenen A; Keeman R; Bolla MK; Wang Q; Soubry A; Wildiers H; Andrulis IL; Arndt V; Beckmann MW; Benitez J; Blomqvist C; Bojesen SE; Brauch H; Brennan P; Brenner H; Chenevix-Trench G; Choi JY; Cornelissen S; Couch FJ; Cox A; Cross SS; Czene K; Eriksson M; Fasching PA; Figueroa J; Flyger H; Giles GG; González-Neira A; Guénel P; Hall P; Hollestelle A; Hopper JL; Ito H; Jones M; Kang D; ; Knight JA; Kosma VM; Li J; Lindblom A; Lilyquist J; Lophatananon A; Mannermaa A; Manoukian S; Margolin S; Matsuo K; Muir K; Nevanlinna H; Peterlongo P; Pylkäs K; Saajrang S; Seynaeve C; Shen CY; Shu XO; Southey MC; Swerdlow A; Teo SH; Tollenaar RAEM; Truong T; Tseng CC; van den Broek AJ; van Deurzen CHM; Winqvist R; Wu AH; Yip CH; Yu JC; Zheng W; Milne RL; Pharoah PDP; Easton DF; Schmidt MK; Garcia-Closas M; Chang-Claude J; Lambrechts D; Neven P
    Breast Cancer Res; 2017 Nov; 19(1):119. PubMed ID: 29116004
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tumor subtype-specific associations of hormone-related reproductive factors on breast cancer survival.
    Song N; Choi JY; Sung H; Jeon S; Chung S; Song M; Park SK; Han W; Lee JW; Kim MK; Yoo KY; Ahn SH; Noh DY; Kang D
    PLoS One; 2015; 10(4):e0123994. PubMed ID: 25875532
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of Parity and Time since Last Birth with Breast Cancer Prognosis by Intrinsic Subtype.
    Sun X; Nichols HB; Tse CK; Bell MB; Robinson WR; Sherman ME; Olshan AF; Troester MA
    Cancer Epidemiol Biomarkers Prev; 2016 Jan; 25(1):60-7. PubMed ID: 26545404
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reproductive factors and risk of estrogen receptor positive, triple-negative, and HER2-neu overexpressing breast cancer among women 20-44 years of age.
    Li CI; Beaber EF; Tang MT; Porter PL; Daling JR; Malone KE
    Breast Cancer Res Treat; 2013 Jan; 137(2):579-87. PubMed ID: 23224237
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of reproductive risk factors and breast cancer molecular subtypes: a systematic review and meta-analysis.
    Mao X; Omeogu C; Karanth S; Joshi A; Meernik C; Wilson L; Clark A; Deveaux A; He C; Johnson T; Barton K; Kaplan S; Akinyemiju T
    BMC Cancer; 2023 Jul; 23(1):644. PubMed ID: 37430191
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of four biomarkers to evaluate the risk of breast cancer subtypes in the women's contraceptive and reproductive experiences study.
    Ma H; Wang Y; Sullivan-Halley J; Weiss L; Marchbanks PA; Spirtas R; Ursin G; Burkman RT; Simon MS; Malone KE; Strom BL; McDonald JA; Press MF; Bernstein L
    Cancer Res; 2010 Jan; 70(2):575-87. PubMed ID: 20068186
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Breastfeeding and breast cancer risk by receptor status--a systematic review and meta-analysis.
    Islami F; Liu Y; Jemal A; Zhou J; Weiderpass E; Colditz G; Boffetta P; Weiss M
    Ann Oncol; 2015 Dec; 26(12):2398-407. PubMed ID: 26504151
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Locoregional recurrence after breast cancer surgery: a systematic review by receptor phenotype.
    Lowery AJ; Kell MR; Glynn RW; Kerin MJ; Sweeney KJ
    Breast Cancer Res Treat; 2012 Jun; 133(3):831-41. PubMed ID: 22147079
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Breast feeding, parity and breast cancer subtypes in a Spanish cohort.
    Redondo CM; Gago-Domínguez M; Ponte SM; Castelo ME; Jiang X; García AA; Fernández MP; Tomé MA; Fraga M; Gude F; Martínez ME; Garzón VM; Carracedo Á; Castelao JE
    PLoS One; 2012; 7(7):e40543. PubMed ID: 22792365
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reproductive and hormonal risk factors for postmenopausal luminal, HER-2-overexpressing, and triple-negative breast cancer.
    Phipps AI; Malone KE; Porter PL; Daling JR; Li CI
    Cancer; 2008 Oct; 113(7):1521-6. PubMed ID: 18726992
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reproductive factors and risk of hormone receptor positive and negative breast cancer: a cohort study.
    Ritte R; Tikk K; Lukanova A; Tjønneland A; Olsen A; Overvad K; Dossus L; Fournier A; Clavel-Chapelon F; Grote V; Boeing H; Aleksandrova K; Trichopoulou A; Lagiou P; Trichopoulos D; Palli D; Berrino F; Mattiello A; Tumino R; Sacerdote C; Quirós JR; Buckland G; Molina-Montes E; Chirlaque MD; Ardanaz E; Amiano P; Bueno-de-Mesquita HB; van Gils CH; Peeters PH; Wareham N; Khaw KT; Key TJ; Travis RC; Weiderpass E; Dumeaux V; Lund E; Sund M; Andersson A; Romieu I; Rinaldi S; Vineis P; Merritt MA; Riboli E; Kaaks R
    BMC Cancer; 2013 Dec; 13():584. PubMed ID: 24321460
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Age-related terminal duct lobular unit involution in benign tissues from Chinese breast cancer patients with luminal and triple-negative tumors.
    Guo C; Sung H; Zheng S; Guida J; Li E; Li J; Hu N; Deng J; Figueroa JD; Sherman ME; Gierach GL; Lu N; Yang XR
    Breast Cancer Res; 2017 May; 19(1):61. PubMed ID: 28545469
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Breast cancer risk factors in relation to molecular subtypes in breast cancer patients from Kenya.
    Sayed S; Fan S; Moloo Z; Wasike R; Bird P; Saleh M; Shaikh AJ; Figueroa JD; Naidoo R; Makokha FW; Gardner K; Oigara R; Njoroge FW; Magangane P; Mutebi M; Chauhan R; Mwanzi S; Govender D; Yang XR
    Breast Cancer Res; 2021 Jun; 23(1):68. PubMed ID: 34174935
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 status in invasive breast cancer: a 3,198 cases study at National Cancer Center, China.
    Zhu X; Ying J; Wang F; Wang J; Yang H
    Breast Cancer Res Treat; 2014 Oct; 147(3):551-5. PubMed ID: 25234844
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Apoptosis-, proliferation, immune function-, and drug resistance- related genes in ER positive, HER2 positive and triple negative breast cancer.
    Kolacinska A; Chalubinska J; Zawlik I; Szymanska B; Borowska-Garganisz E; Nowik M; Fendler W; Kubiak R; Pawlowska Z; Morawiec Z; Szemraj J
    Neoplasma; 2012; 59(4):424-32. PubMed ID: 22489698
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.